Family history of breast cancer as a determinant of the risk of developing endometrial cancer: A nationwide cohort study [5]

Journal of Medical Genetics

Volumn 39, Issue 11, 2002, Pages 826-832

  Kazerouni, N ^a   Schairer, C ^a   Friedman, H B ^a   Lacey Jr , J V ^a   Greene, M H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; TAMOXIFEN;

ADULT; AGED; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; ENDOMETRIUM CANCER; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; HUMAN; LETTER; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MIDDLE AGED; RISK FACTORS; UNITED STATES;

EID: 0036850978     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (63)

1. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1999. National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1973_1999/,2002.
2. Parkin DM. Epidemiology of cancer: Global patterns ond trends. Toxicol Lett 1998;102-103:227-34.
3. Parazzini F, La Vecchia C, Bocciolone L, Franceschi S. The epidemiology of endometrial cancer. Gynecol Oncol 1991;41:1-16.
4. Parslov M, Lidegaard O, Klintorp S, Pedersen B, Jonsson L, Eriksen PS, Ottesen B. Risk factors among young women with endometrial cancer: A Danish case-control study. Am J Obstet Gynecol 2000;182:23-9.
5. Gruber SB, Thompson WD. A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group. Cancer Epidemiol Biomarkers Prev 1996;5:411-17.
6. Schildkraut JM, Risch N, Thompson WD. Evaluating genetic association among ovarian, breast, and endometrial cancer: Evidence for a breast/ovarian cancer relationship. Am J Hum Genet 1989;45:521-9.
7. Olson JE, Sellers TA, Anderson KE, Folsom AR. Does a family history of cancer increase the risk for postmenopausal endometrial carcinoma? A prospective cohort study and a nested case-control family study of older women. Cancer 1999;85:2444-9.
8. Parazzini F, La Vecchia C, Moroni S, Chatenoud L, Ricci E. Family history and the risk of endometrial cancer. Int J Cancer 1994;59:460-2.
9. Nelson CL, Sellers TA, Rich SS, Potter JD, McGovern PG, Kushi LH. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Genet Epidemiol 1993;10:235-44.
10. Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Mostow ED, Schwartz PE, O'Connor T, White C. A case-control study of cancer of the endometrium. Am J Epidemiol 1982;116:333-42.
11. Sasco AJ. Epidemiology of breost cancer: On environmental disease? APMIS 2001;109:321-32.
12. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S. Age at first birth and breast cancer risk. Bull WHO 1970;43:209-21.
13. MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol 1974;2:122-9.
14. Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lannom L, Hoover RN. Reproductive, menstrual, and medical risk factors for endometrial cancer: Results from a case-control study. Am J Obstet Gynecol 1992; 167:1317-25.
15. Lyon FA. The development of adenocarcinoma of the endometrium in young women receiving long-term sequential oral contraception. Am J Obstet Gynecol 1975;123:299-301.
16. Henderson BE, Casagrande JT, Pike MC, Mack T, Rosario I, Duke A. The epidemiology of endometrial cancer in young women. Br J Cancer 1983;47:749-56.
17. Hoover R, Fraumeni JF, Everson R, Myers MH. Cancer of the uterine corpus after hormonal treatment for breast cancer. Lancet 1976;1:885-7.
18. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: A meta-analysis. Obstet Gynecol 1995;85:304-13.
19. Curtis RE, Hoover RN, Kleinerman RA, Harvey EB. Second cancer following cancer of the female genital system in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985;68:113-37.
20. Storm HH, Ewertz M. Second cancer following cancer of the female genital system in Denmark, 1943-80. Natl Cancer Inst Monogr 1985;68:331-40.
21. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985,68:99-112.
22. Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JP, Lees JA, Weng LP, Eng C. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 2000;92:924-30.
23. Eng C. Will the real Cowden syndrome please stand up: Revised diagnostic criteria. J Med Genet 2000;37:828-30.
24. Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 1996;77:1836-43.
25. Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, Du SD, Tucker K, Kirk J. Hereditary nonpolyposis colorectal cancer in 95 families: Differences and similarities between mutation-positive and mutation-negative kindreds. J Hum Genet 2001;68:118-27.
26. Lynch HT, Krush AJ, Lemon HM, Kaplan AR, Condit PT, Bottomley RH. Tumor variation in families with breast cancer. JAMA 1972;222:1631-5.
27. Anderson DE, Badzioch MD. Familial breast cancer risks. Effects of prostate and other cancers. Cancer 1993;72:114-19.
28. Parazzini F, La Vecchia C, Negro E, Franceschi S, Tizzy L. Family history of breast, ovarian and endometrial cancer and risk of breast cancer. Int J Epidemiol 1993;22:614-18.
29. Baker LH. Cancer Detection Demonstration Project: Five-year summary report. CA Cancer J Clin 1982;32:194-225.
30. Anderson DE. A genetic study of human breast cancer. J Natl Cancer Inst 1972;48:1029-34.
31. Anderson DE. Breast cancer in families. Cancer 1977;40:1855-60.
32. Anderson DE. Familial versus sporadic breast cancer. Cancer 1992;70:1740-6.
33. Ottman R, Pike MC, King MC, Casagrande JT, Henderson BE. Familial breast cancer in a population-based series. Am J Epidemiol 1986;123:15-21.
34. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:961-72.
35. Tulinius H, Sigvaldason H, Olafsdottir G, Tryggvadottir L. Epidemiology of breast cancer in families in Iceland. J Med Genet 1992;29:158-64.
36. Lynch HT, Casey MJ, Shaw TG, Lynch JF. Hereditary factors in gynecologic cancer. Oncologist 1998;3:319-38.
37. Lynch HT, KimberLing W, Albano WA, Lynch JF, Biscone K, Schuelke GS, Sandberg AA, Lipkin M, Deschner EE, Mikol YB. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer 1985;56:934-8.
38. Lynch HT, Lanspa S, Smyrk T, Boman B, Watson P, Lynch J. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control. Part I. Cancer Genet Cytogenet 1991;53:143-60.
39. Itoh H, Houlston RS, Harocopos C, Slack J. Risk of cancer death in first-degree relatives of patients with hereditary non-polyposis cancer syndrome (Lynch type II): A study of 130 kindreds in the United Kingdom. Br J Surg 1990;77:1367-70.
40. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85.
41. Vasen HF, Morreau H, Nortier JW. Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 2001;68:1533-5.
42. Müller A, Edmonston TB, Corao DA, Rose DG, Palazzo JP, Becker H, Fry RD, Rueschoff J, Fishel R. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 2002;62:1014-19.
43. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000;11:185-92.
44. Kvale G, Heuch I, Nilssen S. Reproductive factors and cancers of the breast and genital organs - Are the different cancer sites similarly affected? Cancer Detect Prev 1991;15:369-77.
45. La Vecchia C, Franceschi S, Decarli A, Gallus G, Tognoni G. Risk factors for endometrial cancer at different ages. J Natl Cancer Inst 1984;73:667-71.
46. Austin H, Drews C, Partridge EE. A case-control study of endometrial cancer in relation to cigarette smoking, serum estrogen levels, and alcohol use. Am J Obstet Gynecol 1993;169:1086-91.
47. MacMahon B, Austin JH. Association of carcinomas of the breast and corpus uteri. Cancer 1969;23:275-80.
48. Adami HO, Krusemo UB, Bergkvist L, Persson I, Pettersson B. On the age-dependent association between cancer of the breast and of the endometrium. A nationwide cohort study. Br J Cancer 1987;55:77-80.
49. Hoover R, Fraumeni JF, Everson R, Myers MH. Cancer of the uterine corpus after hormonal treatment for breast cancer. Lancet 1976;i:885-7.
50. Jordan VC, Assikis VJ. Endometrial carcinoma and tamoxifen: Clearing up a controversy. Clin Cancer Res 1995;1:467-72.
51. Assikis VJ, Jordan VC. Gynecologic effects of tamoxifen and the association with endometrial carcinoma. Int J Gynaecol Obstet 1995;49:241-57.
52. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst 1995;87:645-51.
53. Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfversward C, Skoog L, Somell A, Theve T, Wilking N, Askergren J, Hjalmar ML. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1989;1:117-20.
54. Schoenberg BS, Greenberg RA, Eisenberg H. Occurrence of certain multiple primary cancers in females. J Natl Cancer Inst 1969;43:15-32.
55. MacMahon B. Risk factors for endametrial cancer. Gynecol Oncol 1974;2:122-9.
56. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994 86:527-37.
57. van Leeuwen FE, Benraadt J, Coebergh JW, Kiemeney LA, Gimbrere CH, Otter R, Schouten LJ, Damhuis RA, Bontenbal M, Diepenhorst FW, van den Belt-Dusebout AW, van Tinteren H. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994;343:448-52.
58. Parent ME, Ghadirian P, Lacroix A, Perret C. The reliability of recollections of family history: Implications for the medical provider. J Cancer Educ 1997;12:114-20.
59. Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H. Familial breast cancer in southern Finland: How prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 2000;36:1143-8.
60. Douglas FS, O'Dair LC, Robinson M, Evans DG, Lynch SA. The accuracy of diagnoses as reported in families with cancer: A retrospective study. J Med Genet 1999;36:309-12.
61. Kerber RA, Slattery ML. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 1997;146:244-8.
62. Love RR, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis 1985;38:289-93.
63. Theis B, Boyd N, Lockwood G, Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 1994;3:321-7.